Autoimmune Diseases  >>  Kenketsu Glovenin-I (normal human immunoglobulin IV)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
NCT01408550: Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Completed
3
56
Japan
NPB-01, Placebo
Nihon Pharmaceutical Co., Ltd
Bullous Pemphigoid
09/13
09/13
NCT02221271: Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome

Completed
3
22
Japan
NPB-01
Nihon Pharmaceutical Co., Ltd
Guillain-Barré Syndrome
08/15
08/15
NCT01824251: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Completed
3
49
Japan
NPB-01, Intravenous immunoglobulin
Nihon Pharmaceutical Co., Ltd
Chronic Inflammatory Demyelinating Polyneuropathy
09/15
09/15

Download Options